Science and Self: Monitoring Response to MS Treatment with Biomarkers and Patient Reported Outcomes

Live Webinar

Wednesday, December 1, 2021

7:00 – 8:00 pm EST

This timely live webinar will provide an overview of the efficacy, safety, side effects, and immune system impact of MS disease-modifying therapies.

With featured speaker:

Edward J. Fox, MD, PhD
Director, MS Clinic of Central Texas
Central Texas Neurology Consultants
Clinical Associate Professor, University of Texas Dell Medical School

Credit Designations

The CMSC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The CMSC designates this activity for a maximum of 1.0 contact hours of nursing continuing professional development (NCPD) (1.0 in the area of pharmacology).
This knowledge-based activity, JA4008165-9999-21-041-L01-P, qualifies for 1.0 contact hours (.10 CEUs) of continuing pharmacy education credit.

This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.

​This activity is supported by independent grants from Bristol Myers Squibb and Novartis Pharmaceuticals Corporation.

About Me

The Continuing Medical Education Program is an integral part of the organization’s overall mission which aims to improve learners’ competence and performance‐in‐practice and ultimately improve patient outcomes.

Related Posts